Asia-Pacific (APAC) and South America are expected to drive the percutaneous coronary interventions (PCI) market to $8.1bn by 2022, according to a report by GlobalData.

Titled “MediPoint: Percutaneous Coronary Interventions – Global Analysis and Market Forecasts”, the report states that countries such as Japan, China, Argentina, Brazil, and Chile will be major growth drivers in the PCI market over the forecast period.

Large population, higher economic growth and pricing structure make China and Japan the main targets for a majority of medical device manufacturers, whereas the PCI market in the US and Europe is anticipated to decline with healthcare providers taking measures for cost containment and reducing overstenting as medical costs continue to rise.

"Three procedures namely standard balloon angioplasty, drug-eluting balloon angioplasty and coronary stenting will witness the highest growth in the APAC region over the forecast period."

The PCI market in APAC is forecast to grow at a compound annual growth rate (CAGR) of 8.6% to exceed $5bn in value by 2022, according to Sheryl Tang, GlobalData’s Analyst covering Medical Devices, who attributes it to improvements in  access to healthcare, awareness of minimally invasive cardiovascular procedures, and availability of new generation devices.

Three procedures namely standard balloon angioplasty, drug-eluting balloon angioplasty and coronary stenting will witness the highest growth in the APAC region over the forecast period.

How well do you really know your competitors?

Access the most comprehensive Company Profiles on the market, powered by GlobalData. Save hours of research. Gain competitive edge.

Company Profile – free sample

Thank you!

Your download email will arrive shortly

Not ready to buy yet? Download a free sample

We are confident about the unique quality of our Company Profiles. However, we want you to make the most beneficial decision for your business, so we offer a free sample that you can download by submitting the below form

By GlobalData
Visit our Privacy Policy for more information about our services, how we may use, process and share your personal data, including information of your rights in respect of your personal data and how you can unsubscribe from future marketing communications. Our services are intended for corporate subscribers and you warrant that the email address submitted is your corporate email address.

See Also:

Tang further states, “North America will see the reverse trend, with procedures declining slowly at a CAGR of -0.6%. This is primarily due to continued concerns with overstenting and stent-related complications. Procedure volumes in Europe, South America, and the Middle East and Africa will grow steadily, at CAGRs of 2.6%, 3.2%, and 0.3%, respectively.”